|
시장보고서
상품코드
2117654
폴리젤린 주사제 시장 규모, 점유율, 성장 분석 : 농도별, 용도별, 최종사용자별, 유통 채널별, 포장별, 지역별 - 업계 예측(2026-2033년)Polygeline Injection Market Size, Share, and Growth Analysis, By Concentration, By Application, By End User, By Distribution Channel, By Packaging, By Region - Industry Forecast 2026-2033 |
||||||
세계의 폴리젤린 주사제 시장 규모는 2024년에 5억 1,240만 달러로 평가되며, 2025년 5억 3,751만 달러에서 2033년까지 7억 8,811만 달러로 확대되어, 예측 기간(2026-2033년) 동안 CAGR 4.9%로 성장할 것으로 전망됩니다.
세계 폴리젤린 주사제 시장은 외과 수술이나 외상 치료 시 혈관 내 용적을 효과적으로 회복시켜 주는 무균 혈장 대체액을 중심으로 전개되고 있으며, 헬스케어 시스템 전반에서 효율적이고 비용 대비 효과가 높은 수액 요법에 대한 필수적인 수요에 힘입어 성장하고 있습니다. 초기에는 인간 알부민을 대체할 수 있는 보다 저렴한 선택지로 보급되었으나, 수술 건수의 증가와 각 지역 정부의 조달 노력 확대에 힘입어 시장은 현저한 성장을 이루고 있습니다. 예산이 중요한 헬스케어 현장에서 체액량 증가 요법의 도입 추세가 두드러지고 있으며, 의료 기관들은 알부민 및 합성 크리스탈로이드와 관련된 비용 절감에 주력하고 있습니다. 이에 따라 특히 공공 헬스케어 분야에서 폴리젤린의 매력이 크게 높아지고 있습니다. 또한, 규제 절차의 합리화로 인해 신규 진입 기업들은 혁신적인 포장 솔루션을 통해 시장 침투를 강화할 수 있게 되었습니다.
세계 폴리젤린 주사제 시장의 성장요인
의료 시설에서의 최소침습 수술 채택 확대는 효과적인 체액 보충제에 대한 수요를 크게 끌어올리고 있으며, 폴리젤린 주사제은 뛰어난 안전성 프로필과 간편한 투여 방법 덕분에 가장 유력한 선택지로 부상하고 있습니다. 의료 종사자들은 폴리젤린의 즉각적인 효과와 다양한 마취법과의 호환성을 높이 평가하고 있으며, 이로 인해 시술 효율이 향상되고 환자 회전율이 개선되고 있습니다. 그 결과, 의료 기관들은 진료에 폴리젤린을 점점 더 많이 도입하고 있어 안정적인 수요가 창출되고 있습니다. 이에 따라 제조사들은 제품 라인업과 유통 채널 확대를 촉진하고 있습니다. 이러한 추세는 궁극적으로 임상 성과를 향상시키는 동시에 운영 비용 관리에도 기여하고 있습니다.
세계 폴리젤린 주사제 시장의 제약요인
세계 폴리젤린 주사제 시장은 주로 취약한 환자에게 유해사건을 유발할 가능성이 있는 면역원성 반응에 대한 우려로 인해, 규제 당국이 주사용 콜로이드 제제에 부과하는 엄격한 감독으로 인한 중대한 제약에 직면해 있습니다. 이러한 경계심 고조로 인해 안전성 주장을 뒷받침하기 위한 철저한 임상 문서화 및 지속적인 시판 후 조사가 필수적으로 요구되고 있으며, 그 결과 승인 절차의 장기화와 개발 비용의 증가를 초래하고 있습니다. 제조사는 엄격한 표시 요건을 준수하고 효과적인 위험 완화 전략을 시행하기 위해 추가 자원을 투입할 수밖에 없으며, 이는 제품의 적시 출시를 방해하고 시장 진입을 제한할 가능성이 있습니다. 그 결과, 의료 종사자들은 확고한 안전성 데이터가 확보될 때까지 이러한 제품의 도입을 미루는 경향이 있으며, 이로 인해 시장 전체의 성장이 둔화될 가능성이 있습니다.
세계 폴리젤린 주사제 시장 동향
세계 폴리젤린 주사제 시장에서는 제품의 무결성을 높이고 오염 위험을 최소화하려는 노력을 반영하여, 첨단 무균 포장 기술을 도입하려는 뚜렷한 추세가 나타나고 있습니다. 듀얼 챔버 바이알이나 첨단 배리어 필름과 같은 혁신적인 기술이 점점 더 널리 보급되고 있으며, 이를 통해 제조사들은 폴리젤린 주사제의 유통 기한을 연장할 수 있게 되었습니다. 이러한 추세는 의료 종사자들의 취급 편의성을 향상시키고, 외래 진료나 신생 클리닉에서의 이용 확대를 촉진할 뿐만 아니라 브랜드 차별화도 강화합니다. 높아지는 환자 안전에 대한 기대에 부응하고, 전 세계 공급망 최적화 노력과 발을 맞추면서, 이러한 변화는 공급업체에 지속가능한 성장과 수익성 향상을 가져다주며, 시장 내 경쟁 우위를 강화하게 될 것입니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 폴리젤린 주사제 시장 규모 : 농도별
세계의 폴리젤린 주사제 시장 규모 : 용도별
세계의 폴리젤린 주사제 시장 규모 : 최종사용자별
세계의 폴리젤린 주사제 시장 규모 : 유통 채널별
세계의 폴리젤린 주사제 시장 규모 : 포장별
세계의 폴리젤린 주사제 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.08.28Global Polygeline Injection Market size was valued at USD 512.4 Million in 2024 and is poised to grow from USD 537.51 Million in 2025 to USD 788.11 Million by 2033, growing at a CAGR of 4.9% during the forecast period (2026-2033).
The global polygeline injection market is centered around a sterile plasma substitute that effectively restores intravascular volume during surgical procedures and trauma care, driven by the essential need for efficient and cost-effective fluid therapy across healthcare systems. Initially popularized as a more affordable option to human albumin, the market has seen significant expansion due to rising surgical procedures and increasing government procurement initiatives in various regions. The growing trend of adopting volume-expanding therapies in budget-conscious healthcare settings is evident, as institutions focus on reducing costs associated with albumin and synthetic crystalloids. This has notably increased polygeline's appeal, particularly in public healthcare sectors, while streamlined regulatory processes enable new entrants to enhance market penetration with innovative packaging solutions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Polygeline Injection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Polygeline Injection Market Segments Analysis
Global polygeline injection market is segmented by concentration, application, end user, distribution channel, packaging and region. Based on concentration, the market is segmented into 3.5% polygeline and other formulations. Based on application, the market is segmented into hypovolemia, surgical volume replacement and trauma care. Based on end user, the market is segmented into hospitals, ambulatory surgical centers and emergency care centers. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on packaging, the market is segmented into glass bottles and flexible bags. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Polygeline Injection Market
The rising adoption of minimally invasive surgeries in healthcare facilities is significantly boosting the demand for effective volume expanders, with polygeline injection emerging as a top choice thanks to its strong safety profile and straightforward administration. Medical professionals appreciate its quick action and compatibility with diverse anesthesia methods, which streamline procedures and improve patient flow. As a result, healthcare providers are increasingly integrating polygeline into their practices, leading to a consistent demand that encourages manufacturers to broaden their product offerings and distribution channels. This trend ultimately enhances clinical outcomes while aiding in the management of operational costs.
Restraints in the Global Polygeline Injection Market
The Global Polygeline Injection market faces significant constraints stemming from the rigorous oversight imposed by regulatory agencies regarding injectable colloids, primarily due to concerns about potential immunogenic responses that could result in adverse effects for vulnerable patients. This heightened vigilance necessitates thorough clinical documentation and ongoing post-marketing surveillance to substantiate safety claims, resulting in prolonged approval processes and elevated development costs. Manufacturers are compelled to invest extra resources to adhere to stringent labeling requirements and implement effective risk mitigation strategies, which can hinder timely product launches and restrict market access. As a result, healthcare providers may be inclined to delay their adoption of these products until robust safety data is available, thereby slowing down overall market growth.
Market Trends of the Global Polygeline Injection Market
The Global Polygeline Injection market is witnessing a notable trend toward the adoption of advanced sterile packaging technologies, reflecting a commitment to enhance product integrity and minimize contamination risks. Innovations such as dual-chamber vials and advanced barrier films are becoming increasingly prevalent, allowing manufacturers to extend the shelf-life of polygeline injections. This trend not only improves handling convenience for healthcare providers, facilitating wider use in outpatient settings and emerging clinics, but also strengthens brand differentiation. By meeting rising patient safety expectations and aligning with global supply chain optimization efforts, this shift positions suppliers for sustained growth and increased profitability, reinforcing their competitive edge in the market.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Polygeline Injection Market Size by Concentration & CAGR (2026-2033)
- Market Overview
- 3.5% Polygeline
- Other Formulations
Global Polygeline Injection Market Size by Application & CAGR (2026-2033)
- Market Overview
- Hypovolemia
- Surgical Volume Replacement
- Trauma Care
Global Polygeline Injection Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Ambulatory Surgical Centers
- Emergency Care Centers
Global Polygeline Injection Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Polygeline Injection Market Size by Packaging & CAGR (2026-2033)
- Market Overview
- Glass Bottles
- Flexible Bags
Global Polygeline Injection Market Size & CAGR (2026-2033)
- North America (Concentration, Application, End User, Distribution Channel, Packaging)
- US
- Canada
- Europe (Concentration, Application, End User, Distribution Channel, Packaging)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Concentration, Application, End User, Distribution Channel, Packaging)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Concentration, Application, End User, Distribution Channel, Packaging)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Concentration, Application, End User, Distribution Channel, Packaging)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- B. Braun SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fresenius SE & Co. KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baxter International Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Grifols, S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CSL Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Octapharma AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kedrion S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biotest AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takeda Pharmaceutical Company Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shanghai RAAS Blood Products Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- China Biologic Products Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Green Cross Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Intas Pharmaceuticals Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Jubilant Pharmova Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Otsuka Holdings Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- JW Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kelun Pharmaceutical Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vifor Pharma Management Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bharat Serums and Vaccines Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
(주말 및 공휴일 제외)
